Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer.

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.

Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome: a mimicker of juvenile idiopathic arthritis.

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers.

5-Carboxylcytosine levels are elevated in human breast cancers and gliomas.

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.

DNA Repair Endonucleases: Physiological Roles and Potential as Drug Targets.

Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor Activity.

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.

Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.

Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.

Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response.

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.

Biological and clinical significance of PARP1 protein expression in breast cancer.